H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $22.00 and traded as high as $24.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Price Performance
The company has a market cap of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The company has a 50-day simple moving average of $22.00 and a 200-day simple moving average of $22.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Stories
- Five stocks we like better than H. Lundbeck A/S
- About the Markup Calculator
- Sizing Up a New Opportunity for NVIDIA Investors
- Investing In Automotive Stocks
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Options Trading – Understanding Strike Price
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.